G
Gillian Armstrong
Researcher at Hoffmann-La Roche
Publications - 2
Citations - 381
Gillian Armstrong is an academic researcher from Hoffmann-La Roche. The author has contributed to research in topics: Rheumatoid arthritis & Rituximab. The author has an hindex of 2, co-authored 2 publications receiving 358 citations.
Papers
More filters
Journal ArticleDOI
Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naïve with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))
Paul Emery,A. Deodhar,William F. C. Rigby,John D. Isaacs,B. Combe,Artur Racewicz,Kevin Latinis,Carlos Abud-Mendoza,Leszek Szczepanski,R. A. Roschmann,A. Chen,Gillian Armstrong,Wendy Douglass,H. Tyrrell +13 more
TL;DR: Rituximab (at 2×500 mg and 2×1000 mg) plus MTX significantly improved clinical outcomes at week 24, which were further improved by week 48, and no significant differences in either clinical or safety outcomes were apparent between the rituxIMab doses.
Journal ArticleDOI
Effect of rituximab on physical function and quality of life in patients with rheumatoid arthritis previously untreated with methotrexate.
William F. C. Rigby,Gianfranco Ferraccioli,Maria Greenwald,Beatriz Zazueta-Montiel,Roy Fleischmann,Siegfried Wassenberg,Sarika Ogale,Gillian Armstrong,Angelika Jahreis,Laura Burke,Christopher M Mela,Annie Chen +11 more
TL;DR: To assess the effect of rituximab plus methotrexate (MTX) compared with MTX alone on patient‐reported outcomes (PROs) and health‐related quality of life (HRQOL) in patients with active early rheumatoid arthritis (RA) previously untreated withMTX.